Search results
Loss-Making Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Expected To Breakeven In The Medium-Term
Simply Wall St. via Yahoo Finance· 9 months agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) is possibly approaching a major achievement in its...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Looks Just Right With A 31% Price Jump
Simply Wall St. via Yahoo Finance· 1 year agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) shares have had a really impressive month, gaining 31%...
Intra-Cellular Therapies Inc's EVP, Chief Medical Officer Suresh Durgam Sells 21,262 Shares
GuruFocus.com via Yahoo Finance· 6 months agoIn a notable insider transaction, EVP and Chief Medical Officer Suresh Durgam of Intra-Cellular...
Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)
Insider Monkey via Yahoo Finance· 3 weeks agoWe recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...
We Think Intra-Cellular Therapies (NASDAQ:ITCI) Can Easily Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 7 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Investors bid Intra-Cellular Therapies (NASDAQ:ITCI) up US$258m despite increasing losses YoY,...
Simply Wall St. via Yahoo Finance· 8 months agoWhile Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shareholders are probably generally happy, the...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript February 22, 2024...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What...
Simply Wall St. via Yahoo Finance· 1 month agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) investors will be delighted, with the company turning...
The three-year returns have been fantastic for Intra-Cellular Therapies (NASDAQ:ITCI) shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) shareholders might be concerned after seeing the share...
Intra-Cellular Therapies Inc Chairman, President & CEO Sharon Mates Sells 61,277 Shares
GuruFocus.com via Yahoo Finance· 3 months agoSharon Mates, Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 61,277...